INTRODUCTION: Thrombotic events are a common and severe complication of endovascular aneurysm treatment with significant impact on patients' outcome. This study evaluates risk factors for thrombus formation and assesses the efficacy and safety of abciximab for clot dissolution. MATERIALS AND METHODS: All patients treated with abciximab during (41 patients) or shortly after (22 patients) intracranial aneurysm coil embolisation were retrieved from the institutional database (2000 to 2007, 1,250 patients). Sixty-three patients (mean age, 55.3 years, +/- 12.8) had received either intra-arterial or intravenous abciximab. Risk factors for clot formation were assessed and the angiographic and clinical outcome evaluated. RESULTS: No aneurysm rupture occurred during or after abciximab application. The intra-procedural rate of total recanalisation was 68.3%. Thromboembolic complications were frequently found in aneurysms of the Acom complex and of the basilar artery, whilst internal carotid artery aneurysms were underrepresented. Two patients died of treatment-related intracranial haemorrhages into preexisting cerebral infarcts. Two patients developed a symptomatic groin haematoma. CONCLUSIONS: Abciximab is efficacious and safe for thrombolysis during and after endovascular intracranial aneurysm treatment in the absence of preexisting ischaemic stroke.
INTRODUCTION:Thrombotic events are a common and severe complication of endovascular aneurysm treatment with significant impact on patients' outcome. This study evaluates risk factors for thrombus formation and assesses the efficacy and safety of abciximab for clot dissolution. MATERIALS AND METHODS: All patients treated with abciximab during (41 patients) or shortly after (22 patients) intracranial aneurysm coil embolisation were retrieved from the institutional database (2000 to 2007, 1,250 patients). Sixty-three patients (mean age, 55.3 years, +/- 12.8) had received either intra-arterial or intravenous abciximab. Risk factors for clot formation were assessed and the angiographic and clinical outcome evaluated. RESULTS: No aneurysm rupture occurred during or after abciximab application. The intra-procedural rate of total recanalisation was 68.3%. Thromboembolic complications were frequently found in aneurysms of the Acom complex and of the basilar artery, whilst internal carotid artery aneurysms were underrepresented. Two patients died of treatment-related intracranial haemorrhages into preexisting cerebral infarcts. Two patients developed a symptomatic groin haematoma. CONCLUSIONS:Abciximab is efficacious and safe for thrombolysis during and after endovascular intracranial aneurysm treatment in the absence of preexisting ischaemic stroke.
Authors: Joon K Song; Yasunari Niimi; Patricia M Fernandez; Jonathan L Brisman; Razvan Buciuc; Mark J Kupersmith; Alejandro Berenstein Journal: AJNR Am J Neuroradiol Date: 2004-08 Impact factor: 3.825
Authors: Andrew J Molyneux; Richard S C Kerr; Ly-Mee Yu; Mike Clarke; Mary Sneade; Julia A Yarnold; Peter Sandercock Journal: Lancet Date: 2005 Sep 3-9 Impact factor: 79.321
Authors: Jin Ho Hwang; Hong Gee Roh; Young Il Chun; Hyun-Seung Kang; Jin Woo Choi; Won-Jin Moon; Joon Cho; Chang Taek Moon; Young Cho Koh Journal: Neuroradiology Date: 2010-06-24 Impact factor: 2.804
Authors: Pankajavalli Ramakrishnan; Albert J Yoo; James D Rabinov; Christopher S Ogilvy; Joshua A Hirsch; Raul G Nogueira Journal: Interv Neurol Date: 2013-10
Authors: Jean-Christophe Gentric; Joelle Brisson; André Lima Batista; Jimmy Ghostine; Jean Raymond; Daniel Roy; Alain Weill Journal: Interv Neuroradiol Date: 2015-05-11 Impact factor: 1.610
Authors: A K Wakhloo; I Linfante; C F Silva; E A Samaniego; G Dabus; V Etezadi; G Spilberg; M J Gounis Journal: AJNR Am J Neuroradiol Date: 2012-04-05 Impact factor: 3.825
Authors: Ryan D Walsh; Kevin M Barrett; Maria I Aguilar; Giuseppe Lanzino; Ricardo A Hanel; David A Miller; Brian W Chong; W David Freeman Journal: Neurocrit Care Date: 2011-08 Impact factor: 3.210
Authors: Jacques Sedat; Yves Chau; Lydiane Mondot; Richard Chemla; Michel Lonjon; Bernard Padovani Journal: Neuroradiology Date: 2013-11-27 Impact factor: 2.804
Authors: Kiarash Golshani; Andrew Ferrel; Mark Lessne; Pratish Shah; Abhineet Chowdhary; Armen Choulakian; Michael J Alexander; Tony P Smith; David S Enterline; Ali R Zomorodi; Gavin W Britz Journal: Surg Neurol Int Date: 2012-07-28